Complement-Based Drug Development Summit leaderboard
  • Wednesday, August 26, 2026
  • About
  • Advertise
  • Subscribe
  • Contact

Pharma Journalist Pharma Journalist -

17th World ADC San Diego Leaderboard
  • Home
  • News
  • Drug Research
  • Clinical Trials
  • Manufacturing
  • Information Technology
  • Packaging & Labeling
  • Diseases
  • Resources
    • Articles
    • Projects
    • Case Studies
    • Industry Reports
    • Interviews
    • White Papers
  • Events
  • Press Releases
Pharma Journalist
  • Home
  • Pharma Journalist
  • Page 281

Author

Pharma Journalist 9023 posts 0 comments

SAE Media Group Announces the date for 2nd Annual Aseptic Processing Conference

May 23, 2022
SAE Media Group reports: The return of the Aseptic Processing Conference 2022, taking place in London, UK, on the 19 and 20 September 2022. Due to its first year’s success and the…
Read More...

Inceptor Bio Announces $37 Million Series A Financing to Develop Cell Therapies for…

May 23, 2022
Inceptor Bio, a biotechnology company advancing cell therapies for difficult-to-treat cancers, announced the closing of a $37 million Series A financing led by Kineticos Ventures.…
Read More...

Novartis Cosentyx (secukinumab) receives positive CHMP opinion for expanded use in childhood…

May 23, 2022
Novartis announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion for Cosentyx (secukinumab), used alone…
Read More...

PTC Therapeutics Receives Positive CHMP Opinion for Upstaza for the Treatment of AADC Deficiency

May 23, 2022
PTC Therapeutics, Inc. announced that Upstaza (eladocagene exuparvovec; PTC-AADC) received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) of the…
Read More...

Be Bio and Resilience Announce Strategic Collaboration to Manufacture Engineered B Cells, a New…

May 23, 2022
Be Biopharma, Inc. (“Be Bio”) and National Resilience, Inc. (Resilience) announced a strategic collaboration to advance initial programs in Be Bio’s rare disease pipeline. Be Bio’s…
Read More...

Atara Biotherapeutics Provides Update on Strategic Collaboration with Bayer

May 23, 2022
Atara Biotherapeutics, Inc. a leader in T-cell immunotherapy, leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for patients with cancer and…
Read More...

AbbVie Submits New Drug Application to FDA for Investigational ABBV-951 (Foscarbidopa/Foslevodopa)…

May 23, 2022
AbbVie announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for ABBV-951 (foscarbidopa/foslevodopa) for the treatment of motor…
Read More...

CHMP Recommends Approval of Lilly and Incyte’s OLUMIANT (baricitinib) as the First and Only…

May 23, 2022
Eli Lilly and Company and Incyte announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for OLUMIANT …
Read More...

PURIFY’22 Takes Chromatography Purification Notches Higher; Industry Rallies Around this Mega Event

May 20, 2022
The mega PURIFY’22 held on 7th April, 2022 at ITC Kohenur, Hyderabad can be summed up as 22 globally acclaimed speakers, addressing 223 delegates who converged from 26 cities across 80…
Read More...

Sinclair Pharma Partners with Vanguard Aesthetics to Launch Silhouette Soft in Malaysia

May 20, 2022
Sinclair Pharma, a global pharmaceutical brand providing aesthetic dermatology and collagen solutions is collaborating exclusively with Vanguard Aesthetics to bring the Silhouette Soft…
Read More...
Prev Next
Microbiome Movement USA Summit 2026
Cell Therapy for Autoimmune Disease Summit
Complement-Based Drug Development Summit
World CNS Summit South Korea
Novel CNS Biomarkers Summit Europe
8th CNS Drug Delivery Summit
Biomarker Operations & Biospecimen Management
2nd Obesity & Weight Loss Drug Development Summit Europe
RNA-Based Therapeutics & Vaccines Summit South Korea
RNA-Targeted Drug Discovery & Development Summit
mRNA Process Development & CMC Summit 2026
TPD & Induced Proximity Summit
Measuring Patient Engagement Summit Europe
Oligonucleotides Analytical Development & CMC Summit
11th CAR-TCR Summit
COPD Drug Development Summit
Neuropsychiatric Drug Development Summit
10th IPF Summit
Model-Informed Drug Development Summit 2026
IMPACCT Real-World Evidence Summit
Raw Materials for Cell & Gene Therapy Summit
Cell & Gene Therapy Summit South Korea
10th Dermatology Drug Development Summit
9th Lab Asset & Facility Management Summit
TRP Supply Chain & Manufacturing Summit
Covalent Drug Discovery & Development Summit
7th Genome Editing Therapeutics Summit
16th World Clinical Biomarkers & Companion Diagnostics Summit
Lipid Nanoparticles Development Summit Europe
iPSC Drug Development Summit
17th World ADC San Diego
Oligonucleotides for CNS Summit
About Us

Pharma Journalist

Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry.

Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry.

Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.

Recent Posts
  • REGENXBIO Delays RGX-121 Filing After Spine MRI Findings
  • Lundbeck Wins EU Orphan Designation for Cushing’s Syndrome Drug
  • Takeda Wins Japan Approval for New Narcolepsy Type 1 Drug
  • GSK Wins Japan Approval for Hepatitis B Functional Cure
  • Gossamer Bio Secures Up to $250 Million for Seralutinib

Industry Reports

Amgen Acquires Dark Blue to Advance Novel AML Treatments

Takeda Expands Entyvio Options Through Halozyme Technology…

Inductive Bio Wins $21M to Build AI Drug Toxicity Models

Alkermes Boosts Offer to Acquire Avadel in Deal Worth Up to…

Novartis Completes Acquisition of Tourmaline Bio to…

Press Releases

2nd T-Cell Engager for Autoimmune Disease Summit to Deliver…

2nd T-Cell Engager for Autoimmune Disease Summit Returns in…

New Era for Autoimmune T-Cell Engagers Takes Centre Stage…

From Innovation to Acquisition: CrossBridge Bio’s ADC…

COPD Foundations Joins the COPD Drug Development Summit

  • About
  • Advertise
  • Subscribe
  • Contact
© 2026 - Pharma Journalist. All Rights Reserved.
Pharma Journalist is a product of
Sign in

Welcome, Login to your account.

Forget password?
Sign in

Recover your password.

A password will be e-mailed to you.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.